Inspire Medical Systems (INSP) Income from Continuing Operations (2017 - 2026)
Inspire Medical Systems (INSP) reported Income from Continuing Operations of 11294000.0 for Q1 2026, down 477.47% on a YoY basis from 2992000.0 in Q1 2025, and down 108.3% sequentially from 136090000.0 in Q4 2025.
Inspire Medical Systems (INSP) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Inspire Medical Systems (INSP) has 10 years of Income from Continuing Operations data on file, last reported at 11294000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 477.47% year-over-year to 11294000.0; the trailing twelve-month figure through Mar 2026 stood at 131136000.0 (up 97.09% YoY), and the FY2025 full-year result was 145422000.0, up 171.77% from the prior year.
- Income from Continuing Operations slipped to 11294000.0 in Q1 2026, from 136090000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 136090000.0 in Q4 2025 to a low of 16801000.0 in Q3 2022.
- A 5-year average of 7157647.06 and a median of 3592000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations soared 366.89% in 2023 and tumbled 477.47% in 2026, its largest moves.
- Tracing INSP's Income from Continuing Operations over 5 years: stood at 3162000.0 in 2022, then soared by 366.89% to 14763000.0 in 2023, then soared by 138.6% to 35224000.0 in 2024, then jumped by 286.36% to 136090000.0 in 2025, then sank by 108.3% to 11294000.0 in 2026.
- Business Quant data shows INSP's Income from Continuing Operations at 11294000.0 in Q1 2026, 136090000.0 in Q4 2025, and 9932000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.17 Bn | 176.91 Mn | -11.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.29 Mn |
| Dec 31, 2025 | 136.09 Mn |
| Sep 30, 2025 | 9.93 Mn |
| Jun 30, 2025 | -3.59 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 35.22 Mn |
| Sep 30, 2024 | 18.53 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | -10.06 Mn |
| Dec 31, 2023 | 14.76 Mn |
| Sep 30, 2023 | -8.50 Mn |
| Jun 30, 2023 | -11.95 Mn |
| Mar 31, 2023 | -15.42 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Sep 30, 2022 | -16.80 Mn |
| Jun 30, 2022 | -14.49 Mn |
| Mar 31, 2022 | -16.69 Mn |
| Dec 31, 2021 | -2.39 Mn |
| Sep 30, 2021 | -10.35 Mn |
| Jun 30, 2021 | -13.06 Mn |